|1.||Donadon, V: 1 article (08/2002)|
|2.||Lirussi, F: 1 article (08/2002)|
|3.||Crepaldi, G: 1 article (08/2002)|
|4.||Velussi, M: 1 article (08/2002)|
|5.||De Monte, A: 1 article (08/2002)|
|6.||Zanette, G: 1 article (08/2002)|
|7.||Beccarello, A: 1 article (08/2002)|
|1.||Alcoholic Liver Diseases (Alcoholic Liver Disease)
08/01/2002 - "To study this, we assessed the effect of a new oral formulation of an antioxidant agent - silybin-beta-cyclodextrin (named IBI/S) - in patients with chronic alcoholic liver disease and concomitant T2DM. "
08/01/2002 - "Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. "
08/01/2002 - "Oral administration silybin-beta-cyclodextrin in patients with T2DM and compensated chronic alcoholic liver disease causes a significant decrease in both glucose and triglyceride plasma levels. "